GEO ID | Reference | GEO platform | No. of tumor samples in dataset | No. of normal samples in dataset | Death event | Median overall survival (mon) | Serous/endometrioid/clear cell/mucinous/others | Grade(I/II/III) | Stage(1/2/3/4) | Debulk optimal(/out of) | Treatment contains platin(/out of) | Treatment contains Taxol (out of) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GSE18520 [22] | Mok SC et al. 2009 | GPL570 | 53 | 10 | 41 | 21 | 53/0/0/0/0 | 0/0/53 | late stagec | NA | NA | NA |
GSE19829 [23] | Konstantinopoulos PA et al. 2010 | GPL570 | 28 | 0 | 17 | 35 | 23/0/0/0/0 | 0/0/28 | 0/2/22/4 | 23/27 | NA | NA |
GSE23554 [24] | Marchion DC et al. 2011 | GPL96 | 28 | 0 | 14 | Â | 28/0/0/0/0 | 2/8/18 | advancedc | 13 | 28 | NA |
GSE26193 [25] | Mateescu B et al.2011 | GPL570 | 107 | 0 | 31 | 36.2 | 79/8/6/8/6 | 7/33/67 | 20/11/59/17 | NA | NA | NA |
GSE27651 [26] | King ER et al. 2011 | GPL570 | 35 | 6normal 8LMPa | NA | NA | 35/0/0/0/0 | 13low22highb | NA | NA | NA | NA |
GSE30161 [27] | Ferriss JS et al. 2012 | GPL570 | 58 | 0 | 36 | 33.1 | 47/5/1/1/2 | 2/19/33 | 0/0/53/5 | 30/56 | 58/58 | 54/58 |
GSE32062 [28] | Yoshihara K et al.2012 | GPL570 | 10 | 0 | NA | NA | 10/0/0/0/0 | 0/0/10 | late stagec | NA | NA | NA |
GSE40595 [29] | Yeung TL et al.2013 | GPL570 | 63 | 14 | NA | NA | 63/0/0/0/0 | 0/0/63 | NA | NA | NA | NA |
GSE44104 [30] | Wu YH et al. 2014 | GPL570 | 60 | 0 | 16 | NA | 28/11/12/9/0 | NA | 17/8/30/5 | NA | NA | NA |
GSE51373 [31] | Koti M et al.2013 | GPL570 | 28 | 0 | NA | NA | 28/0/0/0/0 | highb | 0/5/19/3 | NA | NA | NA |
GSE54388 [32] | Yeung TL et al.2017 | GPL570 | 16 | 6 | NA | NA | 16/0/0/0/0 | highb | NA | NA | NA | NA |
GSE63885 [33] | Lisowska KM et al. 2014 | GPL570 | 101 | 0 | 66 | 36.3 | 73/12/9/0/7 | 0/10/51 | 0/2/64/11 | NA | 75/75 | 41/75 |
GSE65986 [34] | Uehara Y et al.2015 | GPL570 | 55 | 0 | 6 | NA | 16/14/25/0/0 | NA | 30/5/11/9 | NA | NA | NA |
GSE9891 [35] | Tothill RW et al. 2008 | GPL570 | 267 | 18LMPa | NA | NA | 264/20/0/0/1 | 20/99/161 | 24/18/217/22 | NA | NA | NA |